Detalhe da pesquisa
1.
A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance.
Health Qual Life Outcomes
; 22(1): 24, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448967
2.
Healthcare resource utilization of maribavir versus investigator-assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior treatment: Exploratory analysis of the Phase 3 SOLSTICE trial.
Transpl Infect Dis
; 25(3): e14064, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154528
3.
Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature.
Transpl Infect Dis
; 22(6): e13396, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603496
4.
Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.
Health Qual Life Outcomes
; 11: 167, 2013 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24099272
5.
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.
Antivir Ther
; 28(5): 13596535231195431, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657421
6.
Viral load kinetics and the clinical consequences of cytomegalovirus in kidney transplantation.
Front Immunol
; 14: 1302627, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361528
7.
Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation.
J Med Econ
; 25(1): 367-380, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240904
8.
Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey.
Orphanet J Rare Dis
; 16(1): 94, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602292
9.
Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis.
PLoS One
; 15(4): e0231646, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343692
10.
Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.
PLoS One
; 12(10): e0180261, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28991893
11.
Patient Preferences for Chronic Myeloid Leukemia Medication Regimen Attributes and their Potential Impact on Adherence: Results from a Multi-national Conjoint Study.
J Health Econ Outcomes Res
; 2(1): 75-86, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664084
12.
The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis.
Exp Hematol Oncol
; 2(1): 5, 2013 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23422286
13.
Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia.
Curr Med Res Opin
; 28(2): 213-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22168217
14.
Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database.
J Diabetes Complications
; 26(6): 501-5, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22840886
15.
Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD).
J Diabetes Complications
; 26(6): 513-6, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889712